Agios Pharmaceuticals (AGIO) Other Non-Current Assets (2012 - 2026)

Agios Pharmaceuticals' Other Non-Current Assets history runs 15 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• Quarterly Other Non-Current Assets fell 16.73% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 16.73% YoY) and the FY2025 annual result came in at $3.9 million, down 16.79% from the prior year.
• Other Non-Current Assets was $3.9 million for Q1 2026 at Agios Pharmaceuticals, roughly flat from $3.9 million in the prior quarter.
• Across five years, Other Non-Current Assets topped out at $4.7 million in Q4 2024 and bottomed at $2.9 million in Q1 2022.
• A 5-year average of $4.0 million and a median of $4.0 million in 2022 frame the typical range for Other Non-Current Assets.
• Peak annual rise in Other Non-Current Assets reached 36.41% in 2022, while the deepest fall reached 94.57% in 2022.
• Agios Pharmaceuticals' Other Non-Current Assets stood at $4.0 million in 2022, then grew by 2.55% to $4.1 million in 2023, then climbed by 16.44% to $4.7 million in 2024, then declined by 16.79% to $3.9 million in 2025, then changed by 0.0% to $3.9 million in 2026.
• Business Quant data shows AGIO's Other Non-Current Assets at $3.9 million in Q1 2026, $3.9 million in Q4 2025, and $3.9 million in Q3 2025.